Could Paclitaxel-Eluting Stents Be Superior to Strolimus-Eluting Stents for the Treatment of Saphenous Vein Graft Lesions?

被引：2
|
作者：
Brilakis, Emmanouil S.
Banerjee, Subhash
机构：
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2010年 / 106卷 / 09期
关键词：
REGISTRY;
D O I：
10.1016/j.amjcard.2010.08.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1367 / 1368
页数：2
相关论文
共 50 条
  • [41] Treatment of moderate saphenous vein graft lesions with paclitaxel-eluting stents:: Acute and 30-day safety results of a prospective randomized study (the VELETI trial)
    Rodes-Cabau, J.
    Bertrand, O. F.
    DeLarochelliere, R.
    Dery, J.
    Nguyen, C. N.
    Prouix, G.
    Gleeton, O.
    Noeel, B.
    Barbeau, G.
    Roy, L.
    Rouleau, J.
    Boudreault, J.
    Courtis, J.
    Larose, E.
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 91C - 91C
  • [42] Drug-eluting stents in patients on chronic hemodialysis: Paclitaxel-eluting stents vs. limus-eluting stents
    Sardi, Gabriel L.
    Loh, Joshua P.
    Torguson, Rebecca
    Laynez-Carnicero, Ana
    Kitabata, Hironori
    Xue, Zhenyi
    Satler, Lowell F.
    Pichard, Augusto D.
    Waksman, Ron
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2014, 15 (02) : 86 - 91
  • [43] The VELETI II Trial (Sealing Moderate Coronary Saphenous Vein Graft Lesions With Paclitaxel-Eluting Stents) Local Mechanical Intervention Fails to Stop Atheroprogression in Saphenous Vein Grafts
    Mehilli, Julinda
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (11)
  • [44] Recurrent Cardiovascular Events with Paclitaxel-Eluting Versus Bare-Metal Stents in Saphenous Vein Graft Lesions: Insights from the SOS (Stenting of Saphenous Vein Grafts) Trial
    Michael, Tesfaldet T.
    Abdel-karim, Abdul-rahman R.
    Papayannis, Aristotelis
    Lichtenwalter, Christopher
    de Lemos, James A.
    Obel, Owen
    Addo, Tayo
    Roesle, Michele
    Haagen, Donald
    Rangan, Bavana V.
    Saeed, Bilal
    Bissett, Joseph K.
    Sachdeva, Rajesh
    Voudris, Vassilios V.
    Karyofillis, Panagiotis
    Kar, Biswajit
    Rossen, James
    Fasseas, Panayotis
    Berger, Peter B.
    Banerjee, Subhash
    Brilakis, Emmanouil S.
    JOURNAL OF INVASIVE CARDIOLOGY, 2011, 23 (06): : 216 - 219
  • [45] Paclitaxel-eluting stents in coronary artery disease
    Nawarskas, JJ
    Osborn, LA
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (21) : 2241 - 2251
  • [46] Paclitaxel-Eluting Stents: Current clinical experience
    Grube E.
    Buellesfeld L.
    American Journal of Cardiovascular Drugs, 2004, 4 (6) : 355 - 360
  • [47] Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent
    Chen, Jue
    Li, Jian-Jun
    Chen, Ji-Lin
    Qiao, Shu-Bing
    Xu, Bo
    Yang, Yue-Jin
    Gao, Run-Lin
    Qin, Xue-Wen
    Yuan, Jin-Qing
    Yao, Min
    Wu, Yong-Jian
    Liu, Hai-Bo
    Dai, Jun
    You, Shi-Jie
    CORONARY ARTERY DISEASE, 2008, 19 (07) : 507 - 511
  • [48] A novel antirestenosis effect of paclitaxel-eluting stents
    Touchard, AG
    Ungs, M
    Poff, B
    Barry, J
    Russell, ME
    Wilson, G
    Schwartz, RS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 94A - 94A
  • [49] A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
    Hang Ouyang
    Xuehui Zeng
    Chunlei Zhang
    Linli Song
    Jiarui Xu
    Zhihui Hou
    Siya Xie
    Zheng Tao
    Jincai He
    Journal of Cardiothoracic Surgery, 16
  • [50] Safety and efficacy of everolimus-eluting stents versus paclitaxel-eluting stents in a diabetic population
    Laynez, Ana
    Sardi, Gabriel
    Hauville, Camille
    Barbash, Israel M.
    Pakala, Rajbabu
    Torguson, Rebecca
    Xue, Zhenyi
    Satler, Lowell F.
    Pichard, Augusto D.
    Waksman, Ron
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 81 (05) : 759 - 765
12345